CAPTRUST Financial Advisors’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.83K | Buy |
12,072
+904
| +8% | +$661 | ﹤0.01% | 2500 |
|
|
2025
Q1 | $9.01K | Sell |
11,168
-317
| -3% | -$256 | ﹤0.01% | 2341 |
|
|
2024
Q4 | $15.8K | Sell |
11,485
-7,304
| -39% | -$10.1K | ﹤0.01% | 2275 |
|
|
2024
Q3 | $19.5K | Buy |
18,789
+7,393
| +65% | +$7.69K | ﹤0.01% | 2261 |
|
|
2024
Q2 | $19.7K | Buy |
11,396
+889
| +8% | +$1.54K | ﹤0.01% | 2174 |
|
|
2024
Q1 | $25.1K | Buy |
+10,507
| New | +$25.1K | ﹤0.01% | 2111 |
|
|
2023
Q4 | – | Sell |
-42,607
| Closed | -$159K | – | 2680 |
|
|
2023
Q3 | $159K | Buy |
42,607
+18,862
| +79% | +$70.5K | ﹤0.01% | 2353 |
|
|
2023
Q2 | $101K | Buy |
+23,745
| New | +$101K | ﹤0.01% | 2375 |
|
|
2022
Q3 | – | Sell |
-2,725
| Closed | -$20K | – | 2406 |
|
|
2022
Q2 | $20K | Buy |
2,725
+321
| +13% | +$2.36K | ﹤0.01% | 3369 |
|
|
2022
Q1 | $31K | Buy |
2,404
+2,250
| +1,461% | +$29K | ﹤0.01% | 3116 |
|
|
2021
Q4 | $2K | Buy |
154
+29
| +23% | +$377 | ﹤0.01% | 4392 |
|
|
2021
Q3 | $2K | Sell |
125
-513
| -80% | -$8.21K | ﹤0.01% | 4240 |
|
|
2021
Q2 | $9K | Buy |
638
+415
| +186% | +$5.85K | ﹤0.01% | 3587 |
|
|
2021
Q1 | $3K | Buy |
223
+98
| +78% | +$1.32K | ﹤0.01% | 3895 |
|
|
2020
Q4 | $2K | Buy |
+125
| New | +$2K | ﹤0.01% | 3091 |
|
|
2020
Q3 | – | Sell |
-2,000
| Closed | -$36K | – | 3069 |
|
|
2020
Q2 | $36K | Buy |
+2,000
| New | +$36K | ﹤0.01% | 1736 |
|